Benzinga's Top #PreMarket Losers

By: via Benzinga
Genocea Biosciences Inc (NASDAQ: GNCA) fell 31.40 percent to $4.96 in pre-market trading following announcement of suspension of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.